National Institutes of Health: Pituitary Neoplasms trials

The registry lists 11 Pituitary Neoplasms studies with National Institutes of Health as lead sponsor. 3 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 1Phase 2 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• DDAVP for Pituitary AdenomaRecruitingNCT04569591Not applicable
• Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal SurgeryRecruitingNCT03678389Not applicable
• Evaluation and Treatment of Neurosurgical DisordersRecruitingNCT00060541
• Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s DiseaseWithdrawnNCT04339751Phase 2
• Effects of Hormone Stimulation on Brain Scans for Cushing s DiseaseCompletedNCT01459237Early Phase 1
• Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
• Evaluation of Patients With Endocrine-Related ConditionsTerminatedNCT00005664
• The Treatment and Natural History of AcromegalyCompletedNCT00001981
• Sandostatin LAR Depot vs. Surgery for Treating AcromegalyCompletedNCT00001860Phase 2
• Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney ComplexCompletedNCT00001452
• Evaluation of Factors in Human Brain TumorsCompletedNCT00001171